Raghuram Selvaraju

H.C. Wainwright & Co.

Recent Articles about Anavex Life Sciences Corp.

Four-Year Data on New Drug for Early AD Positive 04/09/2025

Long-term treatment with this small molecule seems feasible given its safety and tolerability profile, noted an H.C. Wainwright & Co. report.